Is 1 in 7 Odds a Breakthrough? Is it Even Promising?
Dr. Richard Lehman: Why does having abnormal glucose tests cost the USA $245bn?
Idolatry of the surrogate: Overdiagnosis in diabetes – podcast with Dr. John S. Yudkin
LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week
Monday health news roundup: mostly gems, one dud
USA Today story shows lack of awareness of debate over pre-diabetes classification
Niacin news provides another example of how surrogate outcomes don’t tell whole story
Some skeptical views of NYT front page “race for cholesterol drug” story
Story of Tredaptive “good cholesterol drug” another lesson on surrogate endpoints
Shooting down the Star’s story on breakthrough breast cancer drug